Pieris Pharmaceuticals Inc (PIRS)
0.19
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 15:00
Pieris Pharmaceuticals Cash from Operations (TTM): -47.08M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -47.08M |
June 30, 2023 | -46.14M |
March 31, 2023 | -48.28M |
December 31, 2022 | -59.93M |
September 30, 2022 | -57.94M |
June 30, 2022 | -63.65M |
March 31, 2022 | -18.16M |
December 31, 2021 | -7.66M |
September 30, 2021 | -10.13M |
June 30, 2021 | -3.219M |
March 31, 2021 | -42.90M |
December 31, 2020 | -45.90M |
September 30, 2020 | -46.45M |
June 30, 2020 | -51.54M |
March 31, 2020 | -52.49M |
December 31, 2019 | -52.47M |
September 30, 2019 | -47.55M |
June 30, 2019 | -49.26M |
March 31, 2019 | -47.51M |
Date | Value |
---|---|
December 31, 2018 | -1.066M |
September 30, 2018 | 3.298M |
June 30, 2018 | 52.86M |
March 31, 2018 | 55.32M |
December 31, 2017 | 49.75M |
September 30, 2017 | 47.72M |
June 30, 2017 | 8.944M |
March 31, 2017 | 9.356M |
December 31, 2016 | -14.39M |
September 30, 2016 | -10.15M |
June 30, 2016 | -10.11M |
March 31, 2016 | -7.086M |
December 31, 2015 | -12.71M |
September 30, 2015 | -10.23M |
June 30, 2015 | -6.698M |
March 31, 2015 | -3.615M |
September 30, 2014 | -0.0245M |
June 30, 2014 | -0.0151M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-63.65M
Minimum
Jun 2022
-3.219M
Maximum
Jun 2021
-42.01M
Average
-47.51M
Median
Mar 2019
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -5.026M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -17.82M |
Ampio Pharmaceuticals Inc | -10.55M |